Effectiveness and Safety of Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: Third Interim Analysis of a German Non-Interventional, Prospective, Multicenter Study (ESCALATE-RA)

被引：0
|
作者：
Krueger, Klaus [1 ]
Prothmann, Ulrich [2 ]
Klopsch, Thilo
Behmer, Olaf [3 ]
Hsieh, Min-Jean [3 ]
Jobst, Juergen [3 ]
Klaus, Pascal [3 ]
Meng, Thomas [3 ]
机构：
[1] Praxiszentrum St Bonifatius, Rheumatol, Munich, Germany
[2] Knappschaftsklinikum Saar, Puttlingen, Germany
[3] Pfizer Pharma GmbH, Berlin, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0301
引用
收藏
页码：586 / 589
页数：4
相关论文
共 49 条
  • [41] REAL-WORLD EFFICACY AND SAFETY OF BOCEPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY
    Moog, G.
    Schober, A.
    Antoni, C.
    Bruch, H. R.
    Herrmann, A.
    John, C.
    Steffens, H.
    Leuschner, M.
    Spengler, U.
    Moeller, B.
    Isernhagen, K.
    Hueppe, D.
    Alshuth, U.
    Mauss, S.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S359 - S360
  • [42] PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration
    Nicole Eter
    Zoran Hasanbasic
    Georgios Keramas
    Christine Rech
    Helmut Sachs
    Harald Schilling
    Joachim Wachtlin
    Peter Wiedemann
    Carsten Framme
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 2213 - 2223
  • [43] PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration
    Eter, Nicole
    Hasanbasic, Zoran
    Keramas, Georgios
    Rech, Christine
    Sachs, Helmut
    Schilling, Harald
    Wachtlin, Joachim
    Wiedemann, Peter
    Framme, Carsten
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (08) : 2213 - 2223
  • [44] Efficacy and Safety of Dimethyl Fumarate for the Long-term Treatment of Patients with moderate to severe Psoriasis vulgaris under Practical Conditions: Interim Analysis of the non-interventional Study SKILL at Week 52
    Augustin, M.
    Oji, V
    Kirsch, A.
    Diemert, S.
    Ertner, K.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 39 - 40
  • [45] Interim analysis (n=200) from ELEANOR: a multinational, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer treated with extended adjuvant neratinib in the clinical routine
    Bartsch, Rupert
    Harbeck, Nadia
    Wrobel, Denise
    Zaiss, Matthias
    Terhaag, Jurgen
    Guth, Dagmar
    Distelrath, Andrea
    Wuerstlein, Rachel
    Zahn, Mark-Oliver
    Luftner, Diana
    Schwitter, Michael
    Balic, Marija
    Jackisch, Christian
    Muller, Volkmar
    Rinnerthaler, Gabriel
    Schmidt, Marcus
    Zaman, Khalil
    Schinkothe, Timo
    Resch, Anna
    Breitenstein, Urs
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [46] Multicenter open-label non-interventional study assessing the alteration of activity in ambulatory patients with relapsing forms of MS (RMS) under treatment with COPAXONE® 40 mg tiw - results of an interim analysis of the NIS COPTIVITY
    Ziemssen, T.
    Schulze-Topphoff, U.
    Fendji, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 477 - 477
  • [47] Multicenter open-label non-interventional study assessing the alteration of activity in ambulatory patients with relapsing forms of MS (RMS) under treatment with COPAXONE® 40 mg tiw - results of an interim analysis of the NIS COPTIVITY
    Ziemssen, T.
    Schulze-Topphoff, U.
    Fendji, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 679 - 679
  • [48] Interim analysis (n=200) of ELEANOR: a multi-national, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib in the clinical routine
    Bartsch, R.
    Harbeck, N.
    Wrobel, D.
    Zaiss, M.
    Terhaag, J.
    Guth, D.
    Distelrath, A.
    Wuerstlein, R.
    Zahn, M. -O
    Lueftner, D.
    Schwitter, M.
    Balic, M.
    Jackisch, C.
    Mueller, V
    Rinnerthaler, G.
    Schmidt, M.
    Zaman, K.
    Schinkoethe, T.
    Vannier, C.
    Breitenstein, U.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 170 - 171
  • [49] REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon®) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma
    Welslau, Manfred
    Kubuschok, Boris
    Topaly, Julian
    Otremba, Burkhard
    Wolff, Thomas
    Bryn, Galyna
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
12345